FDA approves GSK's Jideytro (zidesamtinib), its first lung cancer drug, for previously treated ROS1‑positive non-small cell lung cancer
https://finviz.com/stock?t=GSK&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.